The therapy room is quiet except for the soft clicking of a tablet, a steady, mechanical rhythm that fills the pauses between prompts as a technician kneels on the carpet across from a small boy and holds up a laminated card—a horse—waiting for the response that will register as progress.
The boy studies it, his eyes moving from the edges to the center as if the image might change if he looks long enough, and then he taps the card with his finger.
“Horse,” he says, the word landing clearly enough to be counted.
The technician smiles, taps the screen, and logs the answer, another data point secured inside a program designed to build something larger—language, routine, the fragile scaffolding of independence—while down the hallway his mother waits with a paper cup of coffee, watching the clock as the hour advances in quiet increments.
“How’d he do?” she asks when the door opens briefly, her voice low enough not to interrupt the session.
“Good,” the technician says, already half-turned back toward the room. “He’s getting it.”
The reassurance is real, but it exists alongside something else that does not appear in the exchange. The technician guiding the session earns less than twenty dollars for the hour, while that same hour can be billed to Medicaid for several hundred, and the difference between those two numbers is not incidental—it is the structure holding the room in place.
Autism therapy in the United States now runs on a simple unit that carries more weight than it first appears. When care is reimbursed by the hour, the hour becomes the product, and once that unit is fixed, the system begins organizing itself around producing, tracking, and expanding it.
Across the country, thousands of rooms like this one operate inside that logic, and over the past few years autism therapy has become one of the fastest-growing categories of spending within Medicaid, the joint federal–state program that insures more than ninety million Americans. What appears inside the room as incremental progress accumulates outside it as measurable cost.
In 2019, Medicaid spent about $660 million nationwide on autism therapy; by 2023, that figure had reached roughly $2.2 billion, transforming a once-specialized treatment field into a large and rapidly expanding industry.¹ The growth reflects something real, because diagnoses have increased steadily, with federal estimates placing roughly one in 31 American children somewhere on the spectrum, and families searching for help are not imagining the need.¹
Inside clinics, progress remains granular—a word spoken clearly, a task completed without prompting, a gesture repeated until it holds—while outside clinics the same hour converts directly into a claim, processed, reimbursed, and folded into a system that treats time as both care and commodity.
Medicaid pays providers through hourly reimbursement, and once a clinic is approved each hour delivered becomes billable, supported by a funding structure in which the federal government often covers about 70 percent of the cost.² That combination—hourly billing paired with a guaranteed payer—creates conditions where expansion follows a predictable path rather than a speculative one.
Markets do not need to be invented under those conditions. They emerge as clinics open in office parks and converted storefronts, as investors recognize the reliability of government-backed payment, and as hiring accelerates for technicians who deliver the sessions that generate the billable hours, even when those technicians remain near the bottom of the wage scale.
In Indiana, one company—Piece by Piece Autism Centers—illustrates how far that structure can extend once it begins scaling. Founded in 2019 by Meghann Mitchell, a former gymnastics coach who became a behavior analyst, the company followed a model that separates design from delivery: licensed analysts create treatment plans, while registered technicians conduct the sessions that fill the schedule.³
Those technicians typically earned under twenty dollars an hour, while the hours they produced were valued far higher within the reimbursement system, and the gap between labor cost and billable output widened as pricing moved.
When the company began, therapy was priced at about $200 per hour; by late 2023, the listed rate had climbed to roughly $1,600 per hour, with Medicaid reimbursing about 40 percent—around $640 for each hour delivered.⁴ Multiply that across dozens of patients and full weekly schedules, and the totals begin to accelerate in ways that are difficult to reconcile with the simplicity of the room where the work occurs.
In 2023, Indiana Medicaid paid the company $29 million to treat 84 children—about $340,000 per patient—and over five years total payments reached roughly $58 million.³⁵ Mitchell said the company complied with billing rules and passed multiple audits without findings of fraud, and when asked what justified the pricing increases she pointed not to a single cost driver but to decisions made alongside a business partner.⁴
The answer does not sit with the company alone, because the structure that allows it does not originate there.
Autism therapy operates in a part of healthcare that lacks a universal national standard for how many hours a child should receive, leaving treatment plans to be adjusted by clinicians over time, which helps families but removes a natural ceiling on expansion. National Medicaid data show an average of about fourteen hours of therapy per week per patient in 2023, yet many providers billed far more—thirty hours or more weekly for some children, effectively turning therapy into a full-time schedule.⁵
At that level, the system begins to tilt. Providers expand capacity, clinics multiply, and a growing workforce delivers the hours that sustain the model, while oversight moves more slowly, trailing the pace set by reimbursement.
Audits in states including Maine, Wisconsin, Indiana, and Colorado found documentation problems across every sample reviewed, including claims for therapy billed while children were resting or watching videos, a pattern that did not trigger widespread fraud findings but exposed how easily a system built on time can outpace the mechanisms designed to monitor it.²
By the time rules adjust, the structure is already embedded. Indiana eventually replaced its reimbursement formula with a flat rate of roughly $68 per hour, collapsing the previous pricing model almost overnight, and for clinics built on higher reimbursement the shift was not gradual but structural, forcing immediate adaptation.³
Back in the therapy room, the session continues as the technician presents another card and the boy hesitates, then answers, and the tablet records the result while the hour advances minute by minute, each entry marking both progress and completion.
His mother checks the clock again, then looks down at her coffee, which has gone cold without her noticing.
For the family, the hour carries weight that cannot be measured in billing codes. It is an investment in language, in independence, in the possibility that the boy will move through the world with fewer barriers than he would have without it, and that belief holds even when the system surrounding it operates on a different set of incentives.
“What if he needs more?” she asks when the session ends, her voice careful, as if the question itself might increase the answer.
“We can add hours,” the technician says, not hesitating this time.
The offer lands in two directions at once. It expands the child’s access to care, and it increases the volume of what the system recognizes as value, because each additional hour deepens both the intervention and the revenue attached to it.
The room remains what it was—quiet, controlled, built around repetition and small gains—but the structure surrounding it has already made a separate calculation, one that does not depend on any single child yet accumulates through all of them.
It teaches a child how to name the world.
And at the same time, without needing to declare it, it teaches the system how to turn that hour into something it can multiply.
Bibliography
1. The Wall Street Journal. “Autism Therapy Is Fastest-Growing Jackpot in Medicaid.” Investigation of Medicaid spending growth and autism diagnosis trends.
2. The Wall Street Journal. Reporting on Medicaid funding structure and multi-state audits of autism therapy billing.
3. The Wall Street Journal. Coverage of Piece by Piece Autism Centers and Indiana reimbursement changes.
4. The Wall Street Journal. Analysis of therapy pricing and reimbursement rules in Indiana Medicaid.
5. The Wall Street Journal. National Medicaid billing data examining therapy hours and provider concentration.